miR­93­5p regulates the occurrence and development of esophageal carcinoma epithelial cells by targeting TGFßR2.

Cai, Yibin; Ruan, Weizhong; Ding, Jianming; Wei, Ning; Wang, Jianchao; Zhang, Hong; Ma, Ning; Weng, Guibin; Su, Wei Kun; Lin, Yijin; Zhu, Kunshou

miR935p regulates the occurrence and development of esophageal carcinoma epithelial cells by targeting TGFßR2.

Cai, Yibin; Ruan, Weizhong; Ding, Jianming; Wei, Ning; Wang, Jianchao; Zhang, Hong; Ma, Ning; Weng, Guibin; Su, Wei Kun; Lin, Yijin; Zhu, Kunshou.

Afiliación

Cai Y; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Ruan W; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Ding J; Department of Radiotherapy, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Wei N; Department of Chest Radiotherapy, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Wang J; Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Zhang H; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Ma N; Department of Radiotherapy, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Weng G; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Su WK; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Lin Y; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Zhu K; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.

Int J Mol Med ; 47(3)2021 03.

Article en En | MEDLINE | ID: mdl-33448310

Asunto(s)

Células Epiteliales/metabolismo; Neoplasias Esofágicas/metabolismo; MicroARNs/metabolismo; Proteínas de Neoplasias/metabolismo; ARN Neoplásico/metabolismo; Receptor Tipo II de Factor de Crecimiento Transformador beta/metabolismo; Línea Celular Tumoral; Células Epiteliales/patología; Neoplasias Esofágicas/genética; Neoplasias Esofágicas/patología; Humanos; MicroARNs/genética; Proteínas de Neoplasias/genética; ARN Neoplásico/genética; Receptor Tipo II de Factor de Crecimiento Transformador beta/genética

Palabras clave

miR935p; transforming growth factorß receptor 2; esophageal carcinoma; proliferation; migration and invasion; apoptosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ARN Neoplásico / Neoplasias Esofágicas / MicroARNs / Células Epiteliales / Receptor Tipo II de Factor de Crecimiento Transformador beta / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google